TY - JOUR
T1 - Standardization of Nomenclature for Ocular Tuberculosis–Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop
AU - for the Collaborative Ocular Tuberculosis Study (COTS) Group
AU - Agrawal, Rupesh
AU - Agarwal, Aniruddha
AU - Jabs, Douglas A.
AU - Kee, Aera
AU - Testi, Ilaria
AU - Mahajan, Sarakshi
AU - McCluskey, Peter J.
AU - Gupta, Amod
AU - Palestine, Alan
AU - Denniston, Alastair
AU - Banker, Alay
AU - Invernizzi, Alessandro
AU - Fonollosa, Alex
AU - Sharma, Aman
AU - Kumar, Amitabh
AU - Curi, Andre
AU - Okada, Annabelle
AU - Schlaen, Ariel
AU - Heiligenhaus, Arnd
AU - Kumar, Atul
AU - Gurbaxani, Avinash
AU - Bodaghi, Bahram
AU - Islam Shah, Bulbul
AU - Lowder, Careen
AU - Tappeiner, Christoph
AU - Muccioli, Cristina
AU - Vasconcelos-Santos, Daniel Vitor
AU - Goldstein, Debra
AU - Behra, Digambar
AU - Das, Dipankar
AU - Makhoul, Dorine
AU - Baglivo, Edoardo
AU - Denisova, Ekaterina
AU - Miserocchi, Elisabetta
AU - Carreno, Ester
AU - Asyari, Fatma
AU - Pichi, Francesco
AU - Sen, H. Nida
AU - Uy, Harvey
AU - Nascimento, Heloisa
AU - Tugal-Tutkun, Ilknur
AU - Arevalo, J. Fernando
AU - Davis, Janet
AU - Thorne, Jennifer
AU - Hisae Yamamoto, Joyce
AU - Smith, Justine
AU - Garweg, Justus G.
AU - Biswas, Jyotirmay
AU - Babu, Kalpana
AU - Neri, Piergiorgio
N1 - Publisher Copyright:
© 2019 Taylor & Francis Group, LLC.
PY - 2020
Y1 - 2020
N2 - Purpose: To standardize a nomenclature system for defining clinical phenotypes, and outcome measures for reporting clinical and research data in patients with ocular tuberculosis (OTB). Methods: Uveitis experts initially administered and further deliberated the survey in an open meeting to determine and propose the preferred nomenclature for terms related to the OTB, terms describing the clinical phenotypes and treatment and reporting outcomes. Results: The group of experts reached a consensus on terming uveitis attributable to tuberculosis (TB) as tubercular uveitis. The working group introduced a SUN-compatible nomenclature that also defines disease “remission” and “cure”, both of which are relevant for reporting treatment outcomes. Conclusion: A consensus nomenclature system has been adopted by a large group of international uveitis experts for OTB. The working group recommends the use of standardized nomenclature to prevent ambiguity in communication and to achieve the goal of spreading awareness of this blinding uveitis entity.
AB - Purpose: To standardize a nomenclature system for defining clinical phenotypes, and outcome measures for reporting clinical and research data in patients with ocular tuberculosis (OTB). Methods: Uveitis experts initially administered and further deliberated the survey in an open meeting to determine and propose the preferred nomenclature for terms related to the OTB, terms describing the clinical phenotypes and treatment and reporting outcomes. Results: The group of experts reached a consensus on terming uveitis attributable to tuberculosis (TB) as tubercular uveitis. The working group introduced a SUN-compatible nomenclature that also defines disease “remission” and “cure”, both of which are relevant for reporting treatment outcomes. Conclusion: A consensus nomenclature system has been adopted by a large group of international uveitis experts for OTB. The working group recommends the use of standardized nomenclature to prevent ambiguity in communication and to achieve the goal of spreading awareness of this blinding uveitis entity.
KW - Antitubercular therapy
KW - Ocular tuberculosis
KW - remission
KW - tubercular uveitis
KW - tuberculous
KW - uveitis
UR - https://www.scopus.com/pages/publications/85076424820
U2 - 10.1080/09273948.2019.1653933
DO - 10.1080/09273948.2019.1653933
M3 - Article
C2 - 31821096
AN - SCOPUS:85076424820
SN - 0927-3948
VL - 28
SP - 74
EP - 84
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
IS - sup1
ER -
SDG 3 Good Health and Well-being